[Retracted] FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma

Figure 3

Survival outcome, expression difference analyzed by GEPIA, and multivariate Cox analysis of FLG: (a) differential expression of FLG in different disease state (tumor and normal); (b) survival curve of differential FLG expression; (c) differential expression of FLG in different pathological stages; (d) the expression of FLG and multivariate Cox analysis of clinicopathological factors.

(a)

(b)

(c)

(d)